Home › Companies › Biotechnology, Genetics, Health Care, Medical, Therapeutics › Centauri Therapeutics
Centauri Therapeutics
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Centauri Therapeutics operates in biotechnology, genetics, health care, medical, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2015.
Within the biotechnology, genetics, health care, medical, therapeutics space, the company focuses on its core offering rather than a broad product line.
The business is associated with Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $41M.
| Sector | Biotechnology, Genetics, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $40,985,629 |
Website: www.centauritherapeutics.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account